Previous studies on TETs in ESCs and reprogramming have showed that Vc can activate TETs as a cofactor, and a high dose of Vc has rescued TET2 deletion in a mouse model of leukemia (Agathocleous et al., 2017; Cimmino et al., 2017). The gene discussed is TET2; the disease is leukemia.